DESCRIPTION
CJC-1295 Without DAC and Ipamorelin is a dual-component research peptide blend supplied exclusively for controlled laboratory research environments. This lyophilized research material is intended for non-clinical applications involving peptide characterization, analytical method development, and experimental evaluation in model systems. The combination is commonly utilized in laboratory research investigating GHRH receptor signaling, ghrelin receptor activity, and coordinated peptide pathway interactions.
COMPOSITION
• CJC-1295 Without DAC: 5 mg
• Ipamorelin: 5 mg
• Appearance: Lyophilized powder in a sealed research vial
RESEARCH FOCUS (NON-CLINICAL)
• Comparative evaluation of GHRH analog and GHS receptor agonist activity in laboratory model systems
• Analytical assay development and quantitative method validation
• Chromatographic method optimization for impurity profiling of co-formulated peptides
• Stability characterization of lyophilized peptide blends under laboratory storage conditions
DOCUMENTATION
• Lot-specific Certificate of Analysis (COA)
• Batch and lot traceability
• QR code access to product documentation
• Manufacturing quality documentation
IMPORTANT NOTICE
• For research use only
• Not for human consumption
• Not intended for diagnostic, therapeutic, veterinary, or clinical use
• Not intended to diagnose, treat, cure, or prevent any disease
QUALITY & MANUFACTURING
• Manufactured in the USA in an ISO 9001-based, cGMP-aligned facility
• Third-party tested with lot-specific Certificate of Analysis (COA)
• Lyophilized for laboratory stability and secure transit
• Tamper-evident seal with printed lot number and test date
• Each lot documented throughout production
